(3.227.208.0) 您好!臺灣時間:2021/04/20 15:47
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:彭子安
研究生(外文):Zi-An Peng
論文名稱:探討Puerarin於中風動物模式之神經保護作用
論文名稱(外文):The neuroprotective mechanism of puerarin in a transient focal ischemia/reperfusion rat model
指導教授:許準榕
學位類別:碩士
校院名稱:臺北醫學大學
系所名稱:醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2007
畢業學年度:95
語文別:中文
論文頁數:85
中文關鍵詞:缺血性中風葛根素中大腦動脈阻塞神經保護
外文關鍵詞:ischemic strokepuerarinMCAOneuroprotection
相關次數:
  • 被引用被引用:1
  • 點閱點閱:129
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
腦中風一直是國內十大疾病死因之第二位,也是國人失能的主要原因,雖然缺血性腦中風之相關病理機轉受到廣泛研究,但有關治療缺血性腦中風藥物的開發上並無實質的進展,而神經保護製劑為缺血性腦中風的治療藥物之一,然而,臨床上尚未有任何一種神經保護製劑能夠完全避免缺血性腦中風的傷害。由於中大腦動脈為人類缺血性腦中風最容易發生之部位,因此,中大腦動脈缺血再灌流是最常被應於缺血性腦中風藥物研究的動物模式。
Puerarin(4’,7-dihydroxy-8-β-glucosylisoflavone)為中藥葛根(Pueraria lobata)的主要活性成份。根據近年來的研究文獻指出;puerarin具有擴張冠狀動脈、降低體溫以及增加腦部血流的功能,且puerarin亦曾被證實能夠改善動物因心血管以及腦血管病變的微循環。
本實驗評估puerarin對於中大腦動脈缺血再灌流動物模式所引起之傷害是否具有保護作用。另外進一步的探討該藥物是否具有抑制缺血性再灌流傷害所引起之發炎或是細胞凋亡反應的能力。
實驗結果顯示,puerarin (50 mg/kg)能夠有意義地減少因缺血再灌流傷害所引起之梗塞面積。從分子生物層面測試puerarin對神經傷害的保護機轉,經由西方墨點法發現,投與puerarin能夠減少iNOS和HIF-1α 蛋白質表現及減少caspase-3的活化;經由反轉錄-聚合酵素連鎖反應方法分析發現,puerarin能夠減少TNF-α發炎因子以及c-fos mRNA的表現,並能改善Bcl-2的down regulation。除此之外,puerarin在體外實驗中也發現有抑制嗜中性白血球活性的效果。
然而,在鼠腦均質液之脂質過氧化試驗結果中,puerarin並無抑制鐵離子所造成過氧化作用;同時,在電子順磁共振(ESR)測試結果中發現puerarin在體外並無清除自由基的能力。
根據上述這些發現,証實puerarin具有保護神經的能力以減少腦部缺血再灌流的傷害。我們推測此效果的機轉應為透過抑制iNOS、HIF-1α、TNF-α等發炎因子的表現而減少其傷害,抑制嗜中性白血球活化而降低發炎反應的進行。另一方面,puerarin亦能抑制caspase-3以及c-fos的表現、減少Bcl-2 downr egulation進而避免神經細胞的凋亡,然而更詳盡的神經保護機轉仍待進一步的研究
Stroke is still the 2nd leading causes of mortality and morbidity worldwide, it’s also a major factor to make the Taiwanese death and disability.
Although our knowledge concerning the molecular and cellular pathophysiology of brain injury after focal ischemia has advanced greatly, the development of new drugs for acute ischemic stroke has not progressed as rapidly. One strategy for treating acute stroke patients is the development of neuroprotective drugs.
Unfortunately, the clinical trial of using various preclinically neuroprotective drugs for stroke has fail. The middle cerebral artery is the vessel mostly affected by cerebral occlusion in ischemic stroke, thus the middle cerebral artery occlusion (MCAO) of rodents provides an excellent model that is relevant to ischemic stroke in human.
Puerarin(4’,7-dihydroxy-8-β-glucosylisoflavone)is a major active compound extracted from the root of Pueraria lobat, a traditional Chinese medicine. It has been shown to improve microcirculation of cardial and cerebral diseases. In this study, we evaluated the protective effects of puerarin in cerebral ischemia-reperfusion animal injury model.
We found that puerarin (50 mg/kg, ip) markedly attenuated the infarct volume at 24 hours after MCA occlusion/reperfusion. Puerarin pretreatment can significantly reduce protein expression of iNOS and HIF-1α, and inhibit caspase-3 activation in the experiment of Western blotting. Using reverse transcription-polymerase chain reaction analysis,puerarin suppressed the expression of TNF-α mRNA and c-fos, and also decreased Bcl-2 downregulation in the damage cerebral cortex area. On the other hand, we also found that puerarin could inhibit fMLP-induced neutrophils activation in vitro. However, our studies revealled that puerarin has no activities in antioxidantion and free radical scavenging.
In conclusion, we demonstrated that puerarin had neuroprotective effects against cerebral ischemia/reperfusion injury in rats, may involve in : (1) reduction of iNOS and HIF-1α protein expression, (2) suppression of TNF-α and c-fos mRNA expression, (3) prevention of Bcl-2 down regulation, (4) inhibition of caspase-3 activation in vivo and (5) attenuation of fMLP induced-neutrophil activation in vitro. However, the more detailed neuroprotective mechanisms of puerarin will be further investigated in the future.
中文摘要.....................................................................................2
英文摘要.....................................................................................4
縮寫......................................................................................6
壹、緒論........................................................................................10
貳、實驗材料...............................................................................25
叁、實驗方法............................................................................29
肆、實驗結果...............................................................................39
伍、實驗討論…………………………………………………….……..47
陸、結論…………………………………………………………...........56
附圖……………………………………………… ………..................57
圖表……………………………………………………………….59
柒、參考文獻..........................................................................................72
Abe-Dohmae S, Harada N, Yamada K, Tanaka R,. Bcl-2 gene is highly expressed during neurogenesis in the central nervous system.Biochem Biophys Res Commun 1993; 191: 915–921.
Allan K, Wolf HA, Rosenthal CR. The effect of retrieval cues on post-retrieval monitoring in episodic memory: an electrophysiological study. Brain Res Cogn Brain Res 2001; 12: 289-299.
Aronowski J, Grotta JC, Strong R, Waxham MN. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. J Cereb Blood Flow Metab 2000; 20: 343-349.
Arundine M, Tymianski M. Molecular mechanisms of calcium- dependent neurodegeneration in excitotoxicity. Cell Calcium 2003; 34: 325-337.
Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia-the ischemic pnumbra. Stroke 1981; 12723-12725.
Barinaga M. Finding new drugs to treat stroke. Science 1996; 272: 664-666.
Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;
72
17: 472-476.
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17: 1304-1308.
Beere HM, Green DR. Stress manegament-Heat shock protein and regulation of apoptosis. Trends Cell Biol 2001; 11: 6-10.
Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996; 27: 1616-1622.
Belayev L, Busto R, Zhao W, Ginsberg MD. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 1995; 26: 2313-2320.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385: 729-733.
Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 2004; 36: 1187-1205.
Bogousslavsky J, Regli F.Transient global amnesia and stroke. Eur
73
Neurol 1988; 28(2):106-110.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, and Mattson MP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2: 788-794.
Buchan AM, Xue D, Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 1992; 23: 273-279.
Bulkley GB. Free radical-mediated reperfusion injury: a selective review. Br J Cancer Suppl 1987; 8: 66-73.
Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci 1989; 570: 7-22.
Cardenas A, De Alba J, Moro MA, Leza JC, Lorenzo P, Lizasoain I. Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur J Pharmacol 1998; 354: 161-165.
Cardenas A, Moro MA, Hurtado O, Leza JC, Lorenzo P, Castrillo A, Bodelon OG, Bosca L, Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J Neurochem 2000; 74: 2041-2048.
74
Carlson NG, Wieggel WA, Chen J. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6 and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 1999; 163: 3963-3968.
Carroll JE, Howard EF, Hess DC, Wakade CG, Chen Q, Cheng C. Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol 1998; 56: 186-191.
Carolei A, Prencipe M, Fiorelli M. and Fieschi C. Severity of stroke and aspirin. Neurology 1986; 36: 1010-1011.
Chen DF, Schneider GE, Martinou JC, TonegawaS. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997; 385: 434–439.
Chiarugi A. Poly(ADP-ribose) polymerase: killer or conspirator. The suicide hypothesis revisited. Trends Pharmacol Sci 2002; 23: 122-129.
Cole DJ, Cross LM, Drummond JC, Patel PM, Jacobsen WK. Thiopentone and methoxitalm but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth 2001; 48: 807-814.
Dave J, Tortella F (1994) Regional changes in c-fos mRNA in rat brain after i.v. or i.c.v. NMDA injections. Neuroreport 1994; 5:1645–1648.
Dave J, Bauman R, Long J. Hypoxia potentiates traumatic brain
75
injury-induced expression of c-fos in rats. Neuroreport 1997; 8:395–398.
Dawson DA, Martin D, and Hallenbeck JM. Inhibition of tumour necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 1996; 218: 41-44.
De Alba J, Cardenas A, Moro MA, Leza JC, Lorenzo P, Bosca L, Lizasoain I. Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices. J Neurochem 1999; 72: 248-254.
De Bock F, Dornand J, Rondouin G. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 1996; 7: 1125-1129.
Del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 2000; 10: 95-112.
Del Zoppo GJ, Schmid-Schonbein GW, Mori E. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991; 1276-1283.
Dugan LL, Lin TS, He YY, Hsu CY, Choi DW. Detection of free radicals by microdialysis/spin trapping EPR following focal cerebral ischemia-reperfusion and a cautionary note on the stability of 5,5-dimethyl-1-pyrroline N-oxide (DMPO). Free Radic Res 1995; 23:
76
27-32.
Dong LP, Wang TY. Effects of puerarin against glutamate excitotoxicity on cultured mouse cerebral cortical neurons. Acta Pharmacol Sin 1998; 19: 339-342.
Eliasson MJ, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, Moskowitz MA. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci 1999; 19: 5910-5918.
Eliasson MJ, Sampei K, Mandir AS. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3: 1089-1095.
Endoh M, Maiese K, Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 1994; 651: 92-100.
Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J cereb Blood Flow Metab 1997; 17: 1143-1151.
Fan LL, Sun LH, Li J. The protective effect of puerarin againstmyocardial reperfusion injury. Chin Med J 1992; 105:11-17.
Ferrer I, Planas AM. Signaling of cell death and cell survival following focal cerebral ischaemia: life and death struggle in the penumbra. J Neuropath Exp Neurol 2003; 62: 329-339.
77
Ferrer I, Bernet E, Soriano E, Del-Rio T, Fonesca M. Naturally occurring cell death in the cerebral cortex of the rat and removal of death cells by transitory phagocytes. Neuroscience 1990; 39: 451-458.
Ferrer I, TortosaA, Condom E, Blanco R, Macaya A, Planas A, Increased expression of bcl-2 immunoreactivity in the developing cerebral cortex of the rat. Neurosci Lett 1994; 179: 13–16.
Feuerstein GZ. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 1994; 6: 341-360.
Fitz G. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
Fujimura M, Morita-Fujimura Y, Kawase M. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischaemia in mice. J Neurosci. 1999; 19: 3414-3422.
Fisher ED, Bogen JE, Vogel PJ. Cerebral commissurotomy. A second case report. JAMA 1965; Dec 20; 194 (12):1328-1329.
Galea E, Feinstein DL, Reis DJ. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci. USA. 1992; 89: 10945-10949.
Goda N, Dozier SJ, Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 2003; 5: 467-473.
78
Goddard DR, Bunning RA, and Woodroofe MN. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia 2001; 34: 267-271.
Gillardon F, Wickert H, Zimmermann M. UP-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett 1995; 192:85-88.
Gillardon F, Lenz C, Waschke K, Krajewski S, Reed J, Zimmermann M, Kuschinsky W. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Mol Brain Res 1996; 40:254–260.
Grandati M, Verrecchia C, Revaud ML, Allix M, Boulu RG, Plotkine M. Calcium-independent NO-synthase activity and nitrites/nitrates produc- tion in transient focal cerebral ischaemia in mice. Br J Pharmacolm 1997; 122: 625-630.
Grotta J. C., Lemak N. A., Gary H., Fields W. S. and Vital D. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology 1985; 35:632-636.
Guerrini L, Blasi F, Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci. USA 1995; 92: 9077-9081.
Harada H, Wang Y, Mishima Y, Uehara N, Makaya T, Kano T. A novel method of detecting rCBF with laser-Doppler flowmetry without
79
cranial window through the skull for a MCAO rat model. Brain Res Protoc 2005; 14: 165-170.
Hilton M, Middleton G, Davies AM. Bcl-2 influences axonal growth rate in embryonic sensory neurons. Curr Biol 1997; 7: 798-800.
Hirabayashi H, Takizawa S, Fukuyama N, Nakazawa H, Shinohara Y. Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion. Brain Res 2000; 852: 319-325.
Holm KH, Cicchetti F, Bjorklund L, Boonman Z, Tandon P, Costantini LC, Deacon TW, Huang X, Chen DF, Isacson O. Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum. Neuroscience 2001; 104: 397-405.
Hsiao G, Lin YH, Lin CH, Chou DS, Lin WC, Sheu JR. The protective effects of PMC against chronic carbon tetrachloride-induced hepa- totoxicity in vivo. Biol Pharm Bull 2001; 24: 1271-1276.
Hurtado O, Cardenas A, Lizasoain I, Bosca L, Leza JC, Lorenzo P, Moro MA. Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacol 2001; 40: 1094-1102.
Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001; 14: 89-94.
Iadecola C, Ross ME. Molecular pathology of cerebral ischaemia: 80
delayed gene expression and strategies for neuroprotection. Ann N Y Acad Sci 1997; 835: 203-217.
Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996; 27:1373-1380.
Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17: 9157-9164.
Iadecola C, Zhang F, Xu S, Casey R, Ross ME. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995; 15: 378-384.
Iadecola C, Zhang F, Xu S. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 1995; 268: R286-292.
Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neurosci 1997; 20: 132-139.
Johannes Vogela, Markus A, Weigandb, Axel Behrens, Erwin F. Wagner, Marina Schorpp-Kistnere, Manfred Zimmermanna, Johannes Schenkel. Infarct volume after transient middle cerebral artery occlusion (MCAo) can be reduced by attenuation but not by inactivation of c-Jun action. Brain research 2007; 1151:12 -19.
Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Stimulation of ionotropic
81
glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc Natl Acad Sci. USA 1995; 92: 9618-9622.
Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H. Ischemic core and penumbra in human stroke. Stroke 1999; 30:93-99.
Karkkainen I, Rybnikova E, Pelto-Huikko M, and Huovila AP. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 2000; 15: 547-560.
Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediaters ganglioside-induced inflammatory responses in brain microglial cells. J Biol Chem 2002; 277: 40594-40601.
Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115-1127.
Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem 1994; 298: 249-258.
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8: 1-8.
Kopp E, Gosh S. Inhibition of NF-kB by sodium salicylate and aspirin. Science 1994; 265: 956-959.
82
Krupinski J, Lopez E, Marti E. Expression of caspases and their substrates in the rat model of focal cerebral ischaemia. Neurobiol Dis 2000; 7: 332-342.
Krupinski J, Slevin M, Marti E. Time-course phosphorylation of the MAP kinase group of signaling proteins and related molecules following middle cerebral artery occlusion in the rat. Neuropath & App Neurobiol 2003; 29: 144-158.
Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993; 364: 535-537.Le Blanc AC. Natural cellular inhibitors of caspases. Prog Neuro-psychopharmacol Biol Psychiatry 2003 ; 27: 215–229.
Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev 2002; 39: 55-73.
Li J, Zhang X, Sejas DP, Bagby GC, Pang Q. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 2004; 279: 41275-41279.
Liu J, Ginis I, Spatz M and Hallenbeck JM. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol 2000; 278: C144-C153.
Love S. Apoptosis and brain ischaemia. Prog Neuropsychoparmacol Biol Psychiat 2003; 27: 267-282.
Lu X, Tortella F, Ved H, Garcia G, Dave J . Neuroprotective role of c-fos
83
antisense oligonucleotide: in vitro and in vivo studies. Neuroreport 1997; 8:2925–2929.
MacManus JP, Buchan AM., Apoptosis after experimental stroke: Fact or fashion, J Neurotrauma 2000; 17: 899-914.
Madrigal JL, García-Bueno B, Caso JR, Pérez-Nievas BG, Leza JC. Stress-induced oxidative changes in brain. CNS Neurol Disord Drug Targets 2006; 5:561-568.
Manabat C, Han BH, Wendland M, Derugin N, Fox CK, Choi J, Holtzman DM, Ferriero DM, Vexler ZS. Reperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain. Stroke 2003; 34: 207-213.
Markgraf CG, Green EJ, Watson B, McCabe PM, Schneiderman N, Dietrich WD, Ginsberg MD. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke 1994; 25: 153-159.
Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994; 180: 977-984.
Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C. Overexpression of BCL-2 in transgenicmice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13 (4): 1017-1030.
Matrone C, Pignataro G, Molinaro P, Irace C, Scorziello A, Di Renzo G
84
F, Annunziato L. HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J Neurochem 2004; 90: 368-378.
Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab 1996; 16: 114-124.
Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182: 1683-1693.
Memezawa H, Smith ML, Siesjo BK. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992; 23: 552-559.
Minc-Golomb D, Tsarfaty I, Schwartz JP. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br J Pharmacol 1994; 112: 720-722.
Minc-Golomb D, Yadid G, Tsarfaty I, Resau JH, Schwartz JP. In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J Neurochem 1996; 66: 1504-1509.
Moro MA, Cardenas A, Hurtado O, Leza JC, Lizasoain I. Role of nitric oxide after brain ischaemia. Cell calcium 2004; 36: 265-275.
Moro MA, De Alba J, Leza JC, Lorenzo P, Fernandez AP, Bentura ML,
85
Bosca L, Rodrigo J, Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 1998; 10: 445-456.
Nagata S. Apoptosis by death factor. Cell 1997; 88: 55-65.
Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 1997; 17: 483-490.
Nicotera P, Lipton S Excitotoxins in neuronal apoptosis and necrosis. J Cereb Blood Flow Metab 1999; 19:583–591.
Obrenovitch TP. The ischaemic penumbra: twenty years. Cerebrovasc Brain Metab 1995; 7: 297-323.
Parmentier S, Bohme GA, Lerouet D, Damour D, Stutzmann JM, Margaill I, Plotkine M. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol 1999; 127: 546-552.
Parmentier-Batteur S, Bohme GA, Lerouet D, Zhou-Ding L, Beray V, Margaill I, Plotkine M. Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J Cereb Blood Flow Metab 2001; 21: 15-21.
Pearce KA, Boosalis MG, Yeager B. Update on vitamin supplements for the prevention of coronary disease and stroke. Am Fam Physician 2000; 62: 1359-1366.
86
Pentland AP, Morrison AR, Jacobs SC, Hruza LL, Hebert JS, Packer L. Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J Biol Chem 1992; 267: 15578-15584.
Peterson PK , Hu S, Anderson WR, Chao CC. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 1994; 170: 457-460.
Pekoe G., Van Dyke K., Mengoli H., Peden D. and English D. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence. Agents Actions 1982; 12: 232-238.
Phan TG, Wright PM, Markus R. Salvaging the ischaemic penumbra: more than just reperfusion. Clin Exptl Pharmacol 2000; 29: 1-10.
Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein. Biochem Pharmacol 2002; 64: 889-892.
Planas AM, Soriano MA, Estrada A, Sanz O, Martin F, Ferrer I. The heat shock stress response after brain lesions: Induction of 72kDa heat shock protein (cell type involved, axonal transport, transcriptional regulation) and protein synthesis inhibition. Progr Neurobiol 2000; 47: 782-791.
Pulsinelli WA, Jacewicz M, Levy DE, Petito CK, Plum F. Ischemic brain injury and the therapeutic window. Ann N Y Acad Sci 1997; 835: 187-193.
87
Rajdev S, Hara K, Kokubo Y. Mice overexpressing rat heat shock protein 70 is protected against cerebral infarction. Ann Neurol 2000; 47: 782-791.
Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 2004; 89: 1358-1367.
Rimm EB, Stamper MJ, Ascherio A. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
Rong Zhang, Yu-Yu Xue, Shi-Duo Lu, Yao Wang, Ling-Mei Zhang, Ya-Lin Huang, Armando P. Signore, Jun Chen, Feng-Yan Sun. Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiology of Disease 2006; 24 : 345–356.
Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 1975; 255: 332-334.
Rosenbaum DM, Gupta D, D''Amore J, Singh M, Weidenheim K, Zhang H, Kessler JA. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischaemia. J Neurosci Res 2000; 61: 686-692.
Rothwell NJ, Relton JK. Involvement of cytokines in acute
88
neurodegeneration in the CNS. Neurosci Biobehav Rev 1993; 17: 217-227.
Saluja I, O’Regan MH, Song D, Phillis JW. Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochem Res 1999; 24: 669-677.
Saluja I, Song D, O’Regan MH, Phillis JW. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett 1997; 233: 97-100.
Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA 1999; 96: 10964-10967.
Schenkel J. Activation of the c-Jun transcription factor following neurodegeneration in vivo. Neurosci Lett 2004; 361: 36-39.
Schmid T, Zhou J, Brune B. HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 2004;8: 423-431.
Sedarous M, Keramaris E, O''Hare M. Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem 2003; 278: 26031-26038.
Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res 1997; 88: 259-270.
Sheu JR, Lee CR, Hsiao G, Hung WC, Lee YM, Chen YC, Yen MH. Comparison of the relative activities of alpha-tocopherol and PMC
89
on platelet aggregation and antioxidative activity. Life Sci 1999; 65: 197-206.
Siesjo BK, Katsura K, Zhao Q, Folbergrova J, Pahlmark K, Siesjo P, Smith ML. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma 1995; 12: 943-956.
Simmons ML, Murphy S. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 1993; 5: 825-831.
Simmons ML, Murphy S. Induction of nitric oxide synthase in glial cells. J Neurochem 1992; 59: 897-905.
Skovronsky DM, Fath S, Lee VM, and Milla ME. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J Neurobiol 2001; 49: 40-46.
Slevin M, Krupinski J, Kumar P, Gaffney J, Kumar S. Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J Cell Mol Med 2005; 9: 85-102.
Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992; 263:181–191.
Spielberg SP, Boxer LA, Corash LM. Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies. Ann Intern Med 1979; 90: 53-54.
Strinvivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC. 90
In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 1998; 5: 1004-1016.
Stampher MJ, Hennekens CH, Manson JE. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Natl Cancer Inst 1997; 89: 1006-1014.
Strong A, Smith S, Whittington D, Meldrum B, Parsons A, Krupinski J, Hunter J, Patel S, Robertson C. Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarisations in focal cerebral ischaemia. Stroke 2000; 31: 214-222.
Suzuki M, Tabuchi M, Ikeda M, Tomita T. Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Res 2002; 951: 113-120.
Suzuki YJ, Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem Biophys Res Commun 1993; 193: 277-283.
Swanson RA, Morton MT, Tsao WG, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10: 290-293.
Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: description of technique and early 91
neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1: 53-60.
Tananbe H, Eguchi Y., Shimizu. S, Martunou JC, Tsujimoto Y. death-signaling casade in mouse cerebellar granule neurons. Eur J Neurosci 1998 ; 10: 1403-1411.
Thorburn A. Death receptor-induced cell killing. Cellular Signalling 2003; 16: 139-144
Tong L, Toliver-Kinsky T, Taglialatela G, Werrbach-Perez K, Wood T, Perez-Polo J. Signal transduction in neuronal death. J Neurochem 1998; 71:447–459.
Uematsu D, Greenberg JH, Reivich M, Hickey WF. Direct evidence for calcium-induced ischemic and reperfusion injury. Ann Neurol 1989; 26: 280-283.
Vane J. Prostaglandins and Aspirin. Nature 1971 ; 232: 17-19.
Vane J. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235.
Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F,Hibner U, Agid Y. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 1997; 69: 223-231.
Wallace MN, Bisland SK. NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neurosci 1994; 59: 905-919.
92
Wahl F, Obrenovitch T, Hardy A, Plotkine M, Boulu R, Symon L Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency. J Neurochem 1994; 63:1003–1011.
Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, Taub R, Duan JJ, Decicco CP, Liu RQ. Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol 2004; 65:890-896.
Waxham MN, Grotta JC, Silva AJ, Strong R, Aronowski J. Ischemia- induced neuronal damage: A role for calcium/calmodulin-dependent protein kinase II. J Cereb Blood Flow Metab 1996; 16: 1-6.
Winter C, Weiss C, Martin-Villalba A, Zimmermann M, Schenkel J. JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy. Mol. Brain Res 2002; 104: 194-202.
Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
Xiong Fu Liang, Sun Xiao Hui, Gan Lu, Yang Xiang Liang, Xu Hui Bi. Puerarin Protects rat pancreatic islets from damage by hydrogen peroxide. European Journal of Pharmacology 2006; 529:1-7.
Xuan B, Zhou YH, Yang RL. Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther 93
1999;15: 207-216.
Yoshimoto T, Houkin K, Tada M, Abe H. Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model. Acta Neuropathol 1997; 93: 154-158.
Zhang F, Casey RM, Ross ME, Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 1996; 27: 317-323.
Zhang ZG, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischaemia. Trends Cardiovasc Med 2002; 12: 62-66.
Zheng Z, Zhao H, Steinberg GK. Cellular and molecular events underlying ischaemia-induced neuronal apoptosis. Drug News Perspect 2003; 16: 497-503.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 建立葛根中類異黃酮分析條件及不同加工方式對葛根中類異黃酮含量之影響
2. 內源性幹細胞自我拯救和外源性幹細胞治療大鼠缺血性中風之相關分子機轉之探討
3. ASA與TMPZ於暫時性局部腦缺血/再灌流動物模式中神經保護作用之機轉探討
4. 評估神經保護劑褪黑激素於大小鼠腦缺血性中風模式之神經保護效益
5. PMC與TMPZ於暫時性局部腦缺血與再灌流動物模式中神經保護作用之機轉探討
6. 紅花對缺血-再灌流大鼠腦梗塞之效用與tumor necrosis factor-α及interleukin-1β關係之研究
7. 氧氣與葡萄糖剝奪對星狀膠細胞胞外麩氨酸清除功能的影響
8. 等距量尺中文腦中風衝擊量表之發展與應用:不同嚴重度腦中風預後復原趨勢之比較
9. 急性缺血性中風與周邊動脈阻塞疾病相關因素之探討
10. 研究血府逐瘀湯併用血栓溶解劑rt-PA在大鼠自體血塊引發腦血管梗塞的加成效應
11. 探討hinokitiol於中風動物模式之神經保護作用
12. 天麻水萃物對皮質固酮誘導PC12細胞損傷之神經保護功效
13. PeroxisomeProliferator–ActivatedReceptor-γ(PPAR-γ)治療缺血性腦中風之新機制:PPAR-γ透過活化14-3-3-phosphorylatedBad(p-Bad)訊息傳遞路徑來抑制腦中風後粒線體所誘導的神經元細胞凋亡
14. 橙皮素對氧化傷害下PC12細胞之保護作用及其機制探討
15. 高壓氧對於中大腦動脈阻塞大鼠神經保護機制之探討
 
系統版面圖檔 系統版面圖檔